ArticlePharmaceutics2025

A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2.

Aishwarya Saraswat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.